top of page

BackTable / Tumor Board / Podcast / Episode #28

How Biomarkers Enhance Precision Medicine in Non-Muscle Invasive Bladder Cancer

with Dr. Katie Murray and Dr. Sarah Psutka

As new genetic and AI-powered tools emerge for bladder cancer screening, are we getting closer to reducing the need for invasive cystoscopies? In part five of the 2025 BackTable NMIBC Creator Weekend™ series, host Dr. Vignesh Packiam engages in an insightful discussion with Dr. Sarah Psutka from the University of Washington and Dr. Katie Murray from NYU about the complexities and potential benefits of using biomarkers in non-muscle invasive bladder cancer (NMIBC).

This podcast is supported by:

Be part of the conversation. Put your sponsored messaging on this episode. Learn how.

How Biomarkers Enhance Precision Medicine in Non-Muscle Invasive Bladder Cancer with Dr. Katie Murray and Dr. Sarah Psutka on the BackTable Tumor Board Podcast
Ep 28 How Biomarkers Enhance Precision Medicine in Non-Muscle Invasive Bladder Cancer with Dr. Katie Murray and Dr. Sarah Psutka
00:00 / 01:04

BackTable, LLC (Producer). (2025, October 7). Ep. 28 – How Biomarkers Enhance Precision Medicine in Non-Muscle Invasive Bladder Cancer [Audio podcast]. Retrieved from https://www.backtable.com

Stay Up To Date

Follow:

Subscribe:

Sign Up:

Podcast Contributors

Dr. Katie Murray on the BackTable Urology Podcast

Dr. Katie Murray is a urologic oncologist with the University of Missouri.

Dr. Vignesh Packiam on the BackTable Tumor Board Podcast

Dr. Vignesh Packiam is an associate professor of urologic oncology at Rutgers Cancer Institute of New Jersey.

Dr. Sarah Psutka on the BackTable Tumor Board Podcast

Dr. Sarah Psutka is a urologic oncologist and associate professor at University of Washington in Seattle.

Synopsis

The conversation covers the current challenges of interpreting positive biomarkers without clinical correlates, the gold standard of biopsies, and the potential of various biomarkers such as urine cytology, FISH, and newer genomic tests like the Decipher Bladder Genomic Classifier. They also touch upon the role of AI in pathology, the cost implications of biomarkers, and how these tools might influence future clinical practices and patient decisions. The episode emphasizes the need for precision medicine, careful patient counseling, and the impact of false positives and negatives on both patients and healthcare providers.

Timestamps

00:00 - Introduction
05:25 - Challenges with Current Biomarkers
08:10 - New Biomarkers and Genomic Classifiers
21:10 - AI and Pathology in Bladder Cancer
35:13 - Screening and Future Directions
41:20 - Challenges and Future Directions in Bladder Cancer Surveillance
57:51 - Conclusion

Resources

The Materials available on BackTable are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.

backtable-plus-vi-cta.jpg
Become a BackTable Sponsor

Up Next

Lung Cancer Staging & Systemic Therapies: Recent Advancements with Dr. Karen Reckamp and Dr. Scott Atay on the BackTable Tumor Board Podcast
NSCLC Tumor Board Discussion: Considerations for Oligometastatic Disease with Dr. Karen Reckamp, Dr. Scott Atay, Dr. Scott Oh, Dr. Alan Lee and Dr. Scott Genshaft on the BackTable Tumor Board Podcast
Keynote-689: Implementation & Multidisciplinary Care for Immunotherapy in Head & Neck Cancer with Dr. Adam Luginbuhl, Dr. Jennifer Johnson, Dr. Mihir Patel and Dr. Siddharth Sheth on the BackTable Tumor Board Podcast
Complex HCC Patients & The "Grey Zone": What To Do When You Don’t Know What To Do with Dr. Adam Burgoyne, Dr. Zach Berman, Dr. Kirema Garcia-Reyes and Dr. Lingling Du on the BackTable Tumor Board Podcast

Articles

Topics

Oncology Podcasts

Get in touch!

We want to hear from you. Let us know if you’re interested in partnering with BackTable as a Podcast guest, a sponsor, or as a member of the BackTable Team.

bottom of page